Nanoco Group Plc (LON:NANO) CEO Michael Edelman talks to DirectorsTalk about its Quantum Dot technology, commercial applications, heavy metal free technology and efficient mass production processes. With the company changing its commercialisation strategy Michael explains the progress made over the last 2 years in developing its own routes to market and expanding its licensees, opportunities outside of the display market, details around the new partnership and its cash position after a £8m raise last year.
Nanoco Group Plc harnesses the power of nanotechnology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco’s proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar. The company has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany, and Wah Hong Industrial Corporation of Taiwan.
The company was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. It continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.